Literature DB >> 9497971

Nitric oxide and cardiovascular disease.

M McIntyre1, A F Dominiczak.   

Abstract

Endothelium-derived nitric oxide is an important regulatory molecule in cardiovascular function. Reduced availability of nitric oxide has been implicated in the pathogenesis of hypertension and atherosclerosis.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9497971      PMCID： PMC2431478          DOI： 10.1136/pgmj.73.864.630

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  36 in total

1.  Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man.

Authors:  P Vallance; J Collier; S Moncada
Journal:  Lancet       Date:  1989-10-28       Impact factor: 79.321

2.  Role of endothelium-derived relaxing factor in regulation of renal hemodynamic responses.

Authors:  J P Tolins; R M Palmer; S Moncada; L Raij
Journal:  Am J Physiol       Date:  1990-03

3.  Flow-dependent vasodilation of brachial artery in essential hypertension.

Authors:  S Laurent; P Lacolley; P Brunel; B Laloux; B Pannier; M Safar
Journal:  Am J Physiol       Date:  1990-04

4.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine.

Authors:  R F Furchgott; J V Zawadzki
Journal:  Nature       Date:  1980-11-27       Impact factor: 49.962

5.  Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension.

Authors:  M O Ribeiro; E Antunes; G de Nucci; S M Lovisolo; R Zatz
Journal:  Hypertension       Date:  1992-09       Impact factor: 10.190

6.  Vascular endothelial cells synthesize nitric oxide from L-arginine.

Authors:  R M Palmer; D S Ashton; S Moncada
Journal:  Nature       Date:  1988-06-16       Impact factor: 49.962

7.  Effect of local intra-arterial NG-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal.

Authors:  A Calver; J Collier; S Moncada; P Vallance
Journal:  J Hypertens       Date:  1992-09       Impact factor: 4.844

8.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.

Authors:  R M Palmer; A G Ferrige; S Moncada
Journal:  Nature       Date:  1987 Jun 11-17       Impact factor: 49.962

9.  Epicardial coronary artery responses to acetylcholine are impaired in hypertensive patients.

Authors:  C B Treasure; S V Manoukian; J L Klein; J A Vita; E G Nabel; G H Renwick; A P Selwyn; R W Alexander; P Ganz
Journal:  Circ Res       Date:  1992-10       Impact factor: 17.367

10.  Vasodilation to acetylcholine in primary and secondary forms of human hypertension.

Authors:  S Taddei; A Virdis; P Mattei; A Salvetti
Journal:  Hypertension       Date:  1993-06       Impact factor: 10.190
View more
  2 in total

1.  Conway Review Lecture 2001. Atheroma and the mechanics of blood flow in arteries.

Authors:  H M Snow
Journal:  Ir J Med Sci       Date:  2002 Jul-Sep       Impact factor: 1.568

2.  Increased risk of atrial fibrillation among patients undergoing coronary artery bypass graft surgery while receiving nitrates and antiplatelet agents.

Authors:  Jimmy T Efird; Charulata Jindal; Andy C Kiser; Shahab A Akhter; Patricia B Crane; Alan P Kypson; Aaron L Sverdlov; Stephen W Davies; Linda C Kindell; Ethan J Anderson
Journal:  J Int Med Res       Date:  2018-05-29       Impact factor: 1.671
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.